03:48 PM EDT, 06/23/2025 (MT Newswires) -- Health care stocks were softer late Monday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%.

The iShares Biotechnology ETF (IBB) dropped 0.7%.

In corporate news, Lineage Cell Therapeutics ( LCTX ) shares rose 2% after it said Monday its phase 1/2a trial of OpRegen showed consistent improvement in visual acuity for 36 months in a subgroup of patients with geographic atrophy.